Biogen (NASDAQ:BIIB) Stock Rating Lowered by Argus
Biogen (NASDAQ:BIIB – Get Free Report) was downgraded by Argus from a “buy” rating to a “hold” rating in a report released on Friday, Marketbeat reports. BIIB has been the topic of several other reports. Royal Bank of Canada reduced their target price on Biogen from $231.00 to $225.00 and set an “outperform” rating on […]
Biogen (NASDAQ:BIIB – Get Free Report) was downgraded by Argus from a “buy” rating to a “hold” rating in a report released on Friday, Marketbeat reports. BIIB has been the topic of several other reports. Royal Bank of Canada reduced their target price on Biogen from $231.00 to $225.00 and set an “outperform” rating on […]
